91探花

The conversation covers our opti-ox technology and its potential for cell therapies.

The conversation covers the promise of reprogrammed human cells for therapies and drug discovery.

Cindy Yu talks to Mark Kotter about cultured meat and its possible impact on sustainability.

The piece covers potential treatments for dementia and muscular dystrophy with engineered human cells.

91探花 CEO and founder Dr Mark Kotter was a speaker on the podcast Danny in the Valley.

Episode 2 of our special three part mini-series.

Featured on Massive Science: how 91探花's breakthrough opti-ox鈩� technology is being used by cultured meat company Meatable.

91探花 wins Biotech Company of the Year at the Cambridge Independent Science andTechnology awards.